| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
McKesson Europe AG
XHAM:CLS1
McKesson Europe AG
Other Receivables
McKesson Europe AG
Other Receivables Peer Comparison
ILM1
HAEK
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
McKesson Europe AG
XHAM:CLS1
|
Other Receivables
€54.9m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Medios AG
XETRA:ILM1
|
Other Receivables
€2.8m
|
CAGR 3-Years
307%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Haemato AG
XETRA:HAEK
|
Other Receivables
€30.5k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
See Also
What is McKesson Europe AG's Other Receivables?
Other Receivables
54.9m
EUR
Based on the financial report for Mar 31, 2022, McKesson Europe AG's Other Receivables amounts to 54.9m EUR.
What is McKesson Europe AG's Other Receivables growth rate?
Other Receivables CAGR 5Y
-9%
Over the last year, the Other Receivables growth was -63%. The average annual Other Receivables growth rates for McKesson Europe AG have been -34% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
